gefitinib has been researched along with Shock, Septic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abdulkhalek, S; Bandyopadhyay, SK; Chattopadhyay, S; Fensterl, V; Poddar, D; Sen, GC; Veleeparambil, M | 1 |
1 other study(ies) available for gefitinib and Shock, Septic
Article | Year |
---|---|
EGFR kinase activity is required for TLR4 signaling and the septic shock response.
Topics: Animals; ErbB Receptors; Gefitinib; Interferon Regulatory Factors; Interferon-beta; Lipopolysaccharides; Mice; Microarray Analysis; Myeloid Cells; NF-kappa B; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Quinazolines; RAW 264.7 Cells; Shock, Septic; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2015 |